![Cambiando algunos hábitos de vida la incidencia de cáncer podría disminuir un 30%” – Salud y Medicina Cambiando algunos hábitos de vida la incidencia de cáncer podría disminuir un 30%” – Salud y Medicina](https://www.saludymedicina.org/wp-content/uploads/2017/09/DSC0330.jpg)
Cambiando algunos hábitos de vida la incidencia de cáncer podría disminuir un 30%” – Salud y Medicina
Prof. Aleix Prat Head of Medical Oncology Department Hospital Clinic de Barcelona. Spain. Is inviting you all to participate in The 13th BGICC hybrid... | By BGICC-Breast Gynecological & Immunooncology International Cancer
![Aleix PRAT | Head of Department | MD PhD | IDIBAPS August Pi i Sunyer Biomedical Research Institute, Barcelona | IDIBAPS | Translational Genomics and Targeted Therapeutics in Solid Tumors | Research profile Aleix PRAT | Head of Department | MD PhD | IDIBAPS August Pi i Sunyer Biomedical Research Institute, Barcelona | IDIBAPS | Translational Genomics and Targeted Therapeutics in Solid Tumors | Research profile](https://i1.rgstatic.net/ii/profile.image/272398092075057-1441956175008_Q512/Aleix-Prat.jpg)
Aleix PRAT | Head of Department | MD PhD | IDIBAPS August Pi i Sunyer Biomedical Research Institute, Barcelona | IDIBAPS | Translational Genomics and Targeted Therapeutics in Solid Tumors | Research profile
![Omniprex News - Investigadores del Clínic aplicarán la biopsia líquida para detectar la recaída en cáncer de mama Omniprex News - Investigadores del Clínic aplicarán la biopsia líquida para detectar la recaída en cáncer de mama](https://omniprex.com/wp-content/uploads/2018/07/investigadores-clinic.jpg)
Omniprex News - Investigadores del Clínic aplicarán la biopsia líquida para detectar la recaída en cáncer de mama
![Aleix Prat, oncólogo: "Las terapias celulares contra el cáncer avanzan, pero la quimio y la radio seguirán" - El Periódico Aleix Prat, oncólogo: "Las terapias celulares contra el cáncer avanzan, pero la quimio y la radio seguirán" - El Periódico](https://estaticos-cdn.prensaiberica.es/clip/3f366672-a654-4822-85e4-5951e65b6a51_alta-libre-aspect-ratio_default_0.jpg)
Aleix Prat, oncólogo: "Las terapias celulares contra el cáncer avanzan, pero la quimio y la radio seguirán" - El Periódico
![Aleix Prat, oncólogo: “Necesitamos tratar a 10 enfermos de cáncer para que solo se beneficien dos o tres. Es insostenible” | Sociedad | EL PAÍS Aleix Prat, oncólogo: “Necesitamos tratar a 10 enfermos de cáncer para que solo se beneficien dos o tres. Es insostenible” | Sociedad | EL PAÍS](https://imagenes.elpais.com/resizer/GcrVPnqkGnY_gwg4ELHklZu6Maw=/414x0/cloudfront-eu-central-1.images.arcpublishing.com/prisa/JS3P2Y5KRBEEPOVBQX5W4FLFME.jpg)
Aleix Prat, oncólogo: “Necesitamos tratar a 10 enfermos de cáncer para que solo se beneficien dos o tres. Es insostenible” | Sociedad | EL PAÍS
![Aleix Prat «As an oncologist, what I want is for these instruments to be available for use in our practices» - Fundació Bosch i Gimpera Aleix Prat «As an oncologist, what I want is for these instruments to be available for use in our practices» - Fundació Bosch i Gimpera](http://www.fbg.ub.edu/wp-content/uploads/2021/05/2020-APrat-Busto-R-Ap.jpg)
Aleix Prat «As an oncologist, what I want is for these instruments to be available for use in our practices» - Fundació Bosch i Gimpera
![Early Experiences in the United States Helped Shape an International Oncology Career for Aleix Prat, MD, PhD - The ASCO Post Early Experiences in the United States Helped Shape an International Oncology Career for Aleix Prat, MD, PhD - The ASCO Post](https://ascopost.com/media/14018500/56-prat.jpg?anchor=center&mode=crop&width=400&height=300&rnd=132810536600000000)
Early Experiences in the United States Helped Shape an International Oncology Career for Aleix Prat, MD, PhD - The ASCO Post
![Heterogeneity in treatment response in patients with HER2 positive breast cancer (Aleix Prat, Sp... - YouTube Heterogeneity in treatment response in patients with HER2 positive breast cancer (Aleix Prat, Sp... - YouTube](https://i.ytimg.com/vi/7dWDowraq8k/hqdefault.jpg)
Heterogeneity in treatment response in patients with HER2 positive breast cancer (Aleix Prat, Sp... - YouTube
![SOLTI basket trial set to simultaneously evaluate the efficacy of immune-based therapy across multiple cancer types in patients with PD1-high mRNA expressing tumors - VHIO SOLTI basket trial set to simultaneously evaluate the efficacy of immune-based therapy across multiple cancer types in patients with PD1-high mRNA expressing tumors - VHIO](https://vhio.net/wp-content/uploads/2021/07/21_06_12_Aleix-Prat_Josep-Tabernero.jpg)